BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Newcastle Hospitals Clinical Skills Academy - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Newcastle Hospitals Clinical Skills Academy
X-ORIGINAL-URL:https://skillsacademy.newcastle-hospitals.nhs.uk
X-WR-CALDESC:Events for Newcastle Hospitals Clinical Skills Academy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260210T133000
DTEND;TZID=Europe/London:20260210T163000
DTSTAMP:20260406T033302
CREATED:20250923T133528Z
LAST-MODIFIED:20260209T114325Z
UID:10000127-1770730200-1770741000@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Targeted treatments and immunotherapy for Upper GI Cancers
DESCRIPTION:In this half-day course\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – provides an overview of the targeted therapies and immunotherapies given to some people with oesophageal\, stomach\, pancreatic or liver cancer\, or cancers of the biliary system. \nElaine first looks briefly at the gene mutations and faulty processes and pathways that give rise to upper GI cancers and the factors that increase a person’s risk of these diseases. \nShe then turns her attention to the targeted treatments and immunotherapies that are relevant to oesophageal\, gastroesophageal junction\, stomach\, biliary\, liver\, and pancreatic cancer. \nCheckpoint inhibitor therapy is now used widely\, but it isn’t useful against every form of cancer. Elaine looks at why this is the case and why it is largely ineffective against pancreatic cancer. \nElaine will also describe various treatments that target mutated proteins found in cancer cells\, such as HER2\, FGFR\, and IDH1\, and the progress made to date in targeting Claudin 18.2. \nLastly\, Elaine will explain why pancreatic cancer is so difficult to treat and describe two promising strategies: personalised vaccines and Ras protein inhibitors. \nAudience \nThis is a wide-ranging course with lots to cover. Rather than providing a detailed description of the diseases\, Elaine’s focus is on the treatments: how they work\, why they are given to some patients and not others\, and what other treatments are being developed. \nThis course is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with upper GI cancers. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description\nPresentation 1 – Introduction to targeted therapies and immunotherapies for upper GI cancers \n\nAn overview of the faulty genes\, pathways\, and processes that cause cancer\nIntroduction to targeted therapy with antibody-based treatments and kinase inhibitors\nThe relationship between cancer and the immune system\nIntroduction to immunotherapy\n\nPresentation 2 – Treating upper GI cancers with checkpoint inhibitor immunotherapy \n\nHow checkpoint inhibitors work\nBiomarkers of response and resistance\nCombinations\nTiming – advanced vs. early; adjuvant vs. neoadjuvant\n\nPresentation 3 – Targeted therapies for oesophageal\, GEJ\, stomach and liver cancer \n\nHER2-targeted therapies for gastric/GEJ cancers\nFGFR-targeted therapies for gastric/GEJ cancers and cholangiocarcinoma\nTargeting IDH1 in cholangiocarcinoma\nTargeting CLDN18.2 with antibody-based treatments for gastric/GEJ cancers\n\nWhat’s happening with pancreatic cancer? \n\nA perfect storm – the genetic\, molecular and cellular makeup of pancreatic cancer\nPancreatic cancer – targeted treatment approaches and immunotherapies that have been tried and failed\nHow can we make progress against pancreatic cancer?\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos between 3 and 8 minutes long. \nElaine advises “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. Also\, if you’re new to cancer\, I’d recommend the Mutations cause cancer video and\, in order to understand how cancer cells interact with the cells around them\, watch the Tumours are complicated places video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments. If you have more time\, do also watch the videos on kinase inhibitors and immune checkpoint inhibitors.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/targeted-treatments-and-immunotherapy-for-upper-gi-cancers/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2025/09/Upper-GI-Cancer-edit.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
END:VCALENDAR